Chemistry:RU-22930
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| Other names | 5,6-Dihydro-2-methyl-4-[4-nitro-3-(trifluoromethyl)phenyl]-2H-1,2,4-oxadiazin-3-(4H)-one[1] |
| Drug class | Nonsteroidal antiandrogen |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C11H10F3N3O4 |
| Molar mass | 305.213 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
RU-22930 is a nonsteroidal antiandrogen (NSAA) related to the NSAAs flutamide and nilutamide (RU-23908) and was developed by Roussel Uclaf but was never marketed.[2][3] It is a selective antagonist of the androgen receptor and consequently has progonadotropic effects by increasing gonadotropin and testosterone levels via disinhibition of the hypothalamic-pituitary-gonadal axis.[2] Unlike flutamide and nilutamide, the drug is said to be short-acting and inactive by injection, but it has been found to be active topically in animals, and hence could be useful for the treatment of androgen-dependent skin conditions.[2][4]
See also
References
- ↑ "Compositions and methods for inhibiting the action of androgens". https://www.google.com/patents/US4684635.
- ↑ 2.0 2.1 2.2 "Androgen antagonists in androgen target tissues". Pharmacol. Ther. 24 (3): 367–400. 1984. doi:10.1016/0163-7258(84)90010-x. PMID 6205409.
- ↑ "Androgen receptor antagonists (antiandrogens): structure-activity relationships". Curr. Med. Chem. 7 (2): 211–47. 2000. doi:10.2174/0929867003375371. PMID 10637363.
- ↑ Thomson, D. S. (1989). "Pharmacology of Anti-androgens in the Skin". Pharmacology of the Skin II. Handbook of Experimental Pharmacology. 87 / 2. pp. 483–493. doi:10.1007/978-3-642-74054-1_36. ISBN 978-3-642-74056-5.
 |  |
